Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Universal Health Services's 3-Year RORE % for the quarter that ended in Mar. 2026 was 23.87%.
The industry rank for Universal Health Services's 3-Year RORE % or its related term are showing as below:
UHS's 3-Year RORE % is ranked better than 73.48% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 0.74
vs UHS: 23.87
Universal Health Services (NYSE:UHS) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Universal Health Services 3-Year RORE % Related Terms
Universal Health Services 3-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Universal Health Services's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universal Health Services 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Universal Health Services's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Universal Health Services's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
Universal Health Services (UHS) has a 3-Year RORE % of 23.87 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Universal Health Services and its competitors. According to the industry distribution chart, Universal Health Services ranks #161 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 26.5%.
Is Universal Health Services' 3-Year RORE % too high?
Universal Health Services' current 3-Year RORE % is 23.87. The Healthcare Providers & Services industry median 3-Year RORE % is 0.74. Universal Health Services' value of 23.87 is 3125.7% above this industry median. Based on the distribution chart, Universal Health Services ranks #161 out of 607 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Universal Health Services has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Universal Health Services' 3-Year RORE % compare to ENSG and EHC?
According to the Healthcare Providers & Services industry distribution chart, Universal Health Services ranks #161 out of 607 companies for 3-Year RORE %. This puts Universal Health Services in the upper half of its industry. The industry median 3-Year RORE % is 0.74. Universal Health Services' value of 23.87 is 3125.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.74, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Universal Health Services's current 3-Year RORE % of 23.87 is 3125.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Universal Health Services and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Universal Health Services's current 3-Year RORE % is 23.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Health Services stock overvalued right now?
Based on GuruFocus' analysis, Universal Health Services (UHS) is currently considered Significantly Undervalued. The stock's GF Value™ is $228.22, compared to a current price of $145.41 — trading 36.3% below its estimated fair value. The current 3-Year RORE % is 23.87 and 3125.7% above the Healthcare Providers & Services industry median of 0.74. Universal Health Services' overall GF Score™ is 85/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Universal Health Services (UHS), the current 3-Year RORE % is 23.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Universal Health Services (UHS) Overvalued in 2026?
Based on GuruFocus' analysis, Universal Health Services stock appears to be undervalued.
The current stock price of $145.41 is trading 36.3% below its estimated GF Value™ of $228.22.
GuruFocus considers Universal Health Services to be Significantly Undervalued.
Key valuation signals for UHS:
3-Year RORE %: 23.87
GF Value™: $228.22 vs. price of $145.41 (36.3% below fair value)
Industry Position: 3125.7% above the Healthcare Providers & Services median (#161 of 607)
No single metric tells the full story. See the UHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Universal Health Services Inc offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities. As of late 2025, the company operated 346 inpatient behavioral health centers, 29 acute care hospitals, and many supportive outpatient facilities. Its operations are concentrated in the U.S, particularly in Nevada (21% of 2025 operating profits), Texas (19%), and California (13%), although it does have some exposure to the UK behavioral health market (6% of 2025 sales) too. While its acute care services account for over 55% of revenue, the behavioral health centers sport higher margins and account for over 55% of pretax profits.
85GF Score
Get the complete analysis for UHS
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UHS has been successfully added to your 
